Table of Contents Author Guidelines Submit a Manuscript
Case Reports in Vascular Medicine
Volume 2011, Article ID 847241, 4 pages
http://dx.doi.org/10.1155/2011/847241
Case Report

Arterial Thrombosis in Patients with Human Immunodeficiency Virus: Two-Case Reports and Review of the Literature

Abidjan Cardiology Institute, BP 487, Abibjan 22, Cote D'Ivoire

Received 14 June 2011; Accepted 11 July 2011

Academic Editors: S. Guldiken and P.-H. Huang

Copyright © 2011 C. Konin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. C. S. Restrepo, L. Diethelm, J. A. Lemos et al., “Cardiovascular complications of human immunodeficiency virus infection,” Radiographics, vol. 26, no. 1, pp. 213–231, 2006. View at Google Scholar · View at Scopus
  2. J. V. Robbs and N. Paruk, “Management of HIV vasculopathy—a South African experience,” European Journal of Vascular and Endovascular Surgery, vol. 39, supplement 1, pp. S25–S31, 2010. View at Publisher · View at Google Scholar
  3. W. M. Lijfering, H. G. Sprenger, R. R. Georg, P. A. van der Meulen, and J. van der Meer, “Relationship between progression to AIDS and thrombophilic abnormalities in HIV infection,” Clinical Chemistry, vol. 54, no. 7, pp. 1226–1233, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Belda, J. Borrás-Blasco, L. Lopez-Montes, D. Rosique-Robles, E. Casterá, and J. Abad, “Foot ischaemia and toe skin necrosis associated with interleukin-2 infusion in an HIV-infected patient,” International Journal of STD and AIDS, vol. 20, no. 8, pp. 577–579, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. P. Toulon, M. Lamine, I. Ledjev et al., “Heparin cofactor II deficiency in patients infected with the human immunodeficiency virus,” Thrombosis and Haemostasis, vol. 70, no. 5, pp. 730–735, 1993. View at Google Scholar · View at Scopus
  6. A. C. Andrade and B. R. Cotter, “Endothelial function and cardiovascular diseases in HIV infected patient,” Brazilian Journal of Infectious Diseases, vol. 10, no. 2, pp. 139–145, 2006. View at Google Scholar · View at Scopus
  7. C. Fourie, J. van Rooyen, M. Pieters, K. Conradie, T. Hoekstra, and A. Schutte, “Is HIV-1 infection associated with endothelial dysfunction in a population of African ancestry in South Africa?” Cardiovascular Journal of Africa, vol. 22, no. 3, pp. 134–140, 2011. View at Google Scholar
  8. D. Sène, J.-C. Piette, and P. Cacoub, “Antiphospholipid antibodies, antiphospholipid syndrome and viral infections,” Revue de Medecine Interne, vol. 30, no. 2, pp. 135–141, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. S. D. Holmberg, A. C. Moorman, J. M. Williamson et al., “Protease inhibitors and cardiovascular outcomes in patients with HIV-1,” The Lancet, vol. 360, no. 9347, pp. 1747–1748, 2002. View at Publisher · View at Google Scholar · View at Scopus
  10. L. D. S. Martin, E. Pasquier, and N. Roudaut, “Le syndrome métabolique : un risque cardiovasculaire majeur chez les patients séropositifs pour le VIH,” La Presse Médicale, vol. 37, no. 4, 1, pp. 579–584, 2008. View at Publisher · View at Google Scholar
  11. S. Bozzette, C. F. Ake, H. K. Tam, S. W. Chang, and T. H. Louis, “Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection,” New England Journal of Medicine, vol. 348, no. 8, pp. 702–710, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. C. Gazzaruso, P. Sacchi, A. Garzaniti, P. Fratino, R. Bruno, and G. Filice, “Prevalence of metabolic syndrome among HIV patients,” Diabetes Care, vol. 25, no. 7, pp. 1253–1254, 2002. View at Google Scholar · View at Scopus
  13. W. A. Wilson, “Classification criteria for antiphosphilipid syndrome,” Rheumatic Disease Clinics of North America, vol. 27, no. 3, pp. 499–505, 2001. View at Google Scholar
  14. V. Martinez, M. C. Diemert, M. Braibant et al., “Anticardiolipin antibodies in HIV infection are independently associated with antibodies to the membrane proximal external region of gp41 and with cell-associated HIV DNA and immune activation,” Clinical Infectious Diseases, vol. 48, no. 1, pp. 123–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  15. C. Petrovas, P. G. Vlachoyiannopoulos, T. Kordossis, and M. N. Moutsopoulos, “Anti-phospholipid antibodies in HIV infection and SLE with or without anti-phospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with β 2-GPI,” Journal of Autoimmunity, vol. 13, no. 3, pp. 347–355, 1999. View at Publisher · View at Google Scholar